Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024

Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

With an inclination toward patient-centric care delivery, the pharma industry follows a robust, step-by-step approach to market commercialization, with a clear understanding of the market stakeholders, segments, and post-launch forecasts to create seamless go-to-market strategies, develop a positive image, and instill confidence among healthcare providers using scientific data and testimonials. Pharma companies collaborate with third-party logistics providers and adopt adaptive supply chain strategies such as dual sourcing, stockpiling, and advanced scenario planning while tapping the capabilities of established distribution partners to avoid risks and disruptions.

Clearly defined marketing and sales strategies allow pharma companies to navigate regulatory bodies, end-user segments, and other technology vendors.

This Frost Radar™ includes companies that provide cutting-edge solutions and services across the commercialization value chain. The focus areas include supporting managed markets with respect to market access strategies, using AI/ ML-enabled platforms, and omnichannel marketing and sales strategies. Most profiled companies have a global presence.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.